Equity Capital Markets

Company · CIK 1210336

Grant Life Sciences, Inc.

CIK1210336 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inNV
Business addressUT
Listedno ticker on SEC record today
First annual or quarterly report2005-03-31

Offerings

0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

Filings

2
FiledFilingRegistrationAccession
2008-01-29EFFECTDeclared effective 333-1483669999999995-08-000329
2006-12-28EFFECTDeclared effective 333-1377749999999995-06-002920

All filings of this company · CSV